Biopharma News : Biopharma and Pharma news from all around the world :
- Epizyme Announces Pricing of Public Offering of Common Stock
- Sierra Oncology Announces Pricing of Upsized Public Offering of Securities
- Yokogawa Survey Reveals Significant Impact of Industrial Autonomy on Environmental Sustainability
- Zymeworks Announces Pricing of $100.0 Million Public Offering
- TeamBest Global Companies & Best Cyclotron Systems, Inc. Announce Shipment of World’s Very First 6 MeV Proton Cyclotron
- Sheila A. Stamps Joins IQVIA Board of Directors
- US Vaccine Trickle Must be a Flood to End COVID-19, says AHF
- NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4
- Atara Biotherapeutics Enters Strategic Manufacturing Partnership with Fujifilm
- Zymeworks Announces Proposed Public Offering
- Vertex Reports Fourth Quarter 2021 and Full Year Financial Results
- Microbiome Medicine Accelerated by New Partnership Between BiomeBank and Hudson Institute
- Epizyme Announces Proposed Public Offering of Common Stock
- University of Colorado School of Medicine Will Work with DreaMed Diabetes to Deploy Its Advisor System as a New Resource for Diabetes Device Initiation
- Melanoma Research Alliance Statement on FDA Approval of Tebentafusp, the First Drug for Treating Metastatic Uveal Melanoma
- Virus-Like Particles (VLP’s) Market Research Report 2021: Forecast to 2028 with COVID-19 Impact and Global Analysis – ResearchAndMarkets.com
- Pain Management Devices Market Report 2021 – Global Market Size, Forecast, Insights, and Competitive Landscape to 2027 – ResearchAndMarkets.com
- Synergy Biomedical Announces Publication of Core Scientific Study on Its BioSphere Bone Graft Technology
- 6-Hour Virtual Seminar on eCTD Submissions of IND/NDA to the US FDA, EU and Canada – ResearchAndMarkets.com
- 6-Hour Virtual Seminar on EU Regulatory Affairs Strategy During Development of Medicinal Products – ResearchAndMarkets.com
- Eurazeo Invests in Cranial Technologies, the Market Leader in Treating Infant Plagiocephaly
- Dr. Sebastian DiDato joins The Vascular Care Group
- Global COVID-19 Diagnostics Market Report 2022: Technology, Product, Channels – Assay Volumes and 5-Year Market Size Outlook – ResearchAndMarkets.com
- Zero Gravity Solutions, Inc.’s Announces the Publication of an Important Research Paper in the International Journal of Biochemistry Research and Review
- Two Day Online Training Course in Agile Leadership for Pharma and Biopharma Professionals in a Virtual World, March 3rd-4th, 2022 – ResearchAndMarkets.com
- SpotSee Acquires Biosynergy, Inc.
- Global Drug Bioavailability Enhancement Summit 2022: Two Day Online Program – May 16-17, 2022 – ResearchAndMarkets.com
- Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic
- World Reconstituting Injectables at the Point-of-Care Market Research Report 2022 – ResearchAndMarkets.com
- United States e-Prescribing Market Outlook & Forecast Report 2022-2027 – AI to Eradicate Prescription Errors & Develop Indication-Based Prescribing Systems – ResearchAndMarkets.com
Biotech – Biopharma News!
- Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from Right to Try Use of Aviptadil During Omicron Surge
- Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
- Defence Therapeutics Inc.: Defence’s AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9
- Xlife Sciences raises CHF 5.0 million through capital increase
- Lonza Delivers Strong 2021 performance with 20% CER Sales Growth
- Abivax 2022 Financial Communication Calendar
- Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
- MorphoSys ranked Number One in Germany for Female Representation at Leadership Level in European Women on Boards’ Gender Equality Index Report
- Successful completion of FY/2021 with +34% growth in Q4 leading to significant sales increase in 2021 (+30%); further sales growth and EBITDA improvement planned for FY/2022
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs
- Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon ‘Next-Gen’ Colorectal Cancer Screening Test
- Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange
- Kuros Biosciences publishes first-in-human clinical data for Fibrin-PTH (KUR-113) in treatment of open tibial shaft fractures
- Medacta Group SA reports strong revenue growth of 21.4% in 2021
- Zur Rose Group: steady growth in a volatile market environment
- Abivax’s phase 1/2 clinical study results of ABX196 in liver cancer to be presented on Jan. 21, at ASCO GI Cancers Symposium 2022
- Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who’ve Exhausted All Approved Therapies
- Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
- Biotest AG: Biotest combats climate change through CO2-neutral production
- Cheplapharm AG: CHEPLAPHARM AG PLANS FRANKFURT STOCK EXCHANGE LISTING IN Q1 2022
- BRAIN Biotech AG publishes Annual Report for FY 2020/21
- RHÖN-KLINIKUM AG has reached an agreement with the State of Hesse on letter of intent on public investment subsidies
- HAEMATO distributes PCR point-of-care devices for effective containment of corona pandemic
- Geratherm Medical AG: Medical heating blankets for clinical surgery
- Relief Therapeutics Comments on NRx Pharmaceuticals’ Press Release Reporting on its Recently Filed Lawsuit
- Abivax receives EMA Scientific Advice supportive of moving ABX464 into phase 3 clinical testing in ulcerative colitis
- Biotest AG: Biotest AG opens eighth plasma collection centre in Czech Republic
- Relief Comments on Lawsuit Filed Against It by NeuroRx
- BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
- BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
- Mainz Biomed Appoints Steve Quinn as VP Business Development
- Positive Early Access to Medicines Scheme (EAMS) Scientific Opinion Awarded to GBT’s Voxelotor for the Treatment of Haemolytic Anaemia Due to Sickle Cell Disease
- Versius introduced in leading public hospitals in Egypt
- OKYO Pharma Limited- PDMR Dealing
- Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2022
- SELLAS Life Sciences Announces IND Acceptance for First Clinical Trial of GPS in China
- Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions
- Mass General Brigham and The New Commonwealth Fund Partner to Invest in Maternal Health Equity Across Massachusetts
- First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
- Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
- Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- Galapagos appoints Paul Stoffels as Chief Executive Officer
- Cue Biopharma Reports Two Objective Responses (1 cPR and 1uPR) in First Interim Update from Dose Escalation Portion of Ongoing Phase 1 Combination Study of CUE-101 and KEYTRUDA® in First Line Patients with HPV+ Recurrent/Metastatic Head and Neck Cancer
- Privia Health Launches Three New Accountable Care Organizations
- Issuance of 3rd tranche of €500,000 of notes convertibles into new shares
- New Settle Plate Stands for Environmental Monitoring of Pharmaceutical Cleanrooms
- Polaris to Expand Vacaville Site with Acquisition of 15 Acres
- 22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
- Zhittya Genesis Medicine-Parkinson’s Disease-Free Webinar for its Clinical Trial to treat Parkinson’s Disease
- AIM ImmunoTech to Participate in a Solve M.E. Diagnostics and Treatments Webinar
- Aeterna Zentaris Provides Business Outlook and Outlines Pipeline Priorities
- Hepion Pharmaceuticals’ Rencofilstat, in Combination with an Immune Checkpoint Inhibitor, Demonstrates Synergistic Anti-Tumor Activity in a Nonclinical Liver Cancer Study
- Cannabis Global CEO Discusses Corporate Momentum in Audio Interview with SmallCapVoice.com
- BrainsWay Announces Addition of Markus Heilig, M.D., Ph.D., to Scientific Advisory Board
- Philips introduces first at-home, 12-lead ECG integrated solution for decentralized clinical trials
- MRM Health to Present at the 6th Microbiome Movement Drug Development Europe Summit
- eureKARE Joins DNA Data Storage Alliance
- OKYO Pharma Limited – Interim results for the six months to 30 September 2021
- Core One Labs’ Akome Biotech Signs Research Agreement with University of Barcelona, Faculty of Pharmacy and Food Sciences
- Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News